Simplex Trading’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,900
Closed -$36K 10299
2023
Q1
$36K Buy
31,900
+400
+1% +$480 ﹤0.01% 6312
2022
Q4
$35K Sell
31,500
-9,900
-24% -$15.8K ﹤0.01% 6292
2022
Q3
$86K Buy
41,400
+37,600
+989% +$73K ﹤0.01% 5735
2022
Q2
$5K Hold
3,800
﹤0.01% 8897
2022
Q1
$6K Buy
+3,800
New +$5.43K ﹤0.01% 9359

Simplex Trading's RVLP Position: Q1 2024 in Review

Simplex Trading sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2024, closing a stake of 6,900 shares.

Simplex Trading first reported a position in RVLP in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold RVLP as of Q1 2024.

  • Simplex Trading reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 6,900 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2024.
  • Simplex Trading first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and held it in 4 quarters.
  • Simplex Trading's RVL Pharmaceuticals plc Ordinary Shares position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.